Latest News

US FDA awards orphan drug designation to Minoryx’s MIN-102 compound

US FDA awards orphan drug designation to Minoryx’s MIN-102 compound

Abivax to screen new antiviral molecules to develop therapeutic candidates against dengue fever

French biotechnology company Abivax has discovered new antiviral molecules and is screening them to develop therapeutic candidates against dengue fever....

Abivax to screen new antiviral molecules to develop therapeutic candidates against dengue fever

Valeant and EyeGate sign licensing agreement

Valeant Pharmaceuticals has signed an agreement for global commercial and manufacturing rights to US-based EyeGate Pharmaceuticals’ new technology and EGP-437 combination product candidate to...

Valeant and EyeGate sign licensing agreement

US FDA grants fast-track designation to Cell Medica's CMD-003

The US Food and Drug Administration (FDA) has granted fast-track designation to UK-based cellular immunotherapy firm Cell Medica's oncology product CMD-003...

US FDA grants fast-track designation to Cell Medica's CMD-003

Recipharm acquires Kemwell’s pharmaceutical businesses in India for $118.5m

Sweden's Recipharm has completed the previously announced acquisition of Kemwell’s pharmaceutical businesses in Bengaluru, India, in a deal valued at Skr1.05bn...

Recipharm acquires Kemwell’s pharmaceutical businesses in India for $118.5m

Mereo BioPharma’s BPS-804 drug accepted for participation in EMA’s adaptive pathways programme

UK-based biopharmaceutical company Mereo BioPharma has announced that its BPS-804 drug has been accepted to participate in the European Medicines Agency’s (EMA) adaptive pathways programme....

Mereo BioPharma’s BPS-804 drug accepted for participation in EMA’s adaptive pathways programme

Amygdala Neurosciences to acquire GS-6637 from Gilead Sciences

US-based Amygdala Neurosciences has signed an agreement to acquire GS-6637, a ALDH2 inhibitor from Gilead...

Amygdala Neurosciences to acquire GS-6637 from Gilead Sciences

Vedanta, Stanford and Leiden universities partner to study food allergies in children

US-based Vedanta Biosciences has collaborated with Stanford University School of Medicine and Leiden University Medical Center to study food allergies in children and patients with C...

Vedanta, Stanford and Leiden universities partner to study food allergies in children

ALK receives acceptance for ragweed sublingual allergy immunotherapy tablet

Danish-based pharmaceutical company ALK’s European regulatory filing for its ragweed sublingual allergy immunotherapy (SLIT) tablet has received acceptance from the relevant health...

ALK receives acceptance for ragweed sublingual allergy immunotherapy tablet

Japan’s Takeda acquires US cancer drug manufacturer ARIAD for $5.2bn

Japan’s Takeda acquires US cancer drug manufacturer ARIAD for $5.2bn

AMAG Pharmaceuticals signs US licence agreement for Intrarosa

AMAG Pharmaceuticals has signed a licence agreement for US commercial rights to Intrarosa (prasterone)....

AMAG Pharmaceuticals signs US licence agreement for Intrarosa

Mundipharma and Helsinn expand licensing and distribution agreements for Aloxi and Akynzeo

Mundipharma and Helsinn Group have expanded licensing and distribution agreements for anti-emetic prophylactic agents Aloxi and Akynzeo to cover additional markets such as the Middle East,...

Mundipharma and Helsinn expand licensing and distribution agreements for Aloxi and Akynzeo

Ritter and UBC to study role of microbiome and RP-G28 in environmental enteropathy

Ritter Pharmaceuticals has partnered with the University of British Columbia (UBC)’s Michael Smith Laboratories in Canada to explore development of microbiome and RP-G28 in...

Ritter and UBC to study role of microbiome and RP-G28 in environmental enteropathy

Novimmune and LegoChem evaluate antibody drug conjugate candidate

Swiss biotech company Novimmune and South Korean-based LegoChem Biosciences (LCB) have entered a research collaboration to evaluate an antibody drug conjugate...

Novimmune and LegoChem evaluate antibody drug conjugate candidate

Ipsen to acquire five consumer healthcare products from Sanofi

French pharmaceutical company Ipsen has signed an agreement to acquire five consumer healthcare products in certain European territories from Sanofi for...

Ipsen to acquire five consumer healthcare products from Sanofi

Aurobindo Pharma buys four biosimilar products from TL Biopharmaceutical

Indian company Aurobindo Pharma has acquired four cell culture-derived biosimilar products from Swiss-based TL Biopharmaceutical....

Aurobindo Pharma buys four biosimilar products from TL Biopharmaceutical

NewLink Genetics selects Cevec’s CAP Technologies to develop Zika vaccine

German company Cevec Pharmaceuticals has signed an agreement with NewLink Genetics for the use of its CAPGT and CAPGo cell lines in the development and commercialisation of products to treat...

NewLink Genetics selects Cevec’s CAP Technologies to develop Zika vaccine

Espero acquires global rights to Durlaza extended release capsules

Espero Pharmaceuticals has acquired the global rights to the US Food and Drug Administration (FDA)-approved Durlaza (aspirin) extended release...

Espero acquires global rights to Durlaza extended release capsules

Wellcome Trust grants funding to Exonate to develop wet AMD

Wellcome Trust grants funding to Exonate to develop wet AMD

Renova takes over rights to heart failure candidate stresscopin from Janssen

Renova takes over rights to heart failure candidate stresscopin from Janssen

Belgium’s Ablynx submits marketing authorisation application for caplacizumab approval

Belgium’s Ablynx submits marketing authorisation application for caplacizumab approval
cachename:Newscachekey:rd-137342983_-779801984_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_541212976